NCT04773756View on ClinicalTrials.gov

Evaluation of Sofosbuvir and Daclatasvir Combo in COIVD-19 Patients in Egypt

PHASE4CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

November 30, 2020

Study Completion Date

December 12, 2020

Conditions
Covid19
Interventions
DRUG

Sofosbuvir 400 MG/ Daclatasvir 60mg

Giving these two drugs for treatment of COVID patients

Trial Locations (1)

21521

Amr Aly Abd elmoety, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER

NCT04773756 - Evaluation of Sofosbuvir and Daclatasvir Combo in COIVD-19 Patients in Egypt | Biotech Hunter | Biotech Hunter